1-4 of 4
Iqbal S. Grewal, Ph.D.
Close
Sort by
Journal Articles

The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.

Timothy S. Lewis, PhD, Renee S. McCormick, B.S., Kim Kissler, B.S., Ivan J. Stone, B.S., Mechthild Jonas, Ph.D., May S.K. Sutherland, Ph.D., Hans-Peter Gerber, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2342.
https://doi.org/10.1182/blood.V110.11.2342.2342
Published: 2007
Journal Articles

Targeted Depletion and Inhibition of Activated T Lymphocytes with SGN-70, a Humanized Antibody Specific for the Activation Antigen CD70.

Julie A. McEarchern, PhD, Kerry Klussman, B.S., Tamar E. Boursalian, Ph.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1728.
https://doi.org/10.1182/blood.V108.11.1728.1728
Published: 2006
Journal Articles

SGN-70, a Humanized Anti-CD70 Antibody, Targets CD70-Expressing Hematologic Tumors.

Julie A. McEarchern, PhD, Charlotte F. McDonagh, Ph.D., Leia M. Smith, Ph.D., Kerry Klussman, B.S., Ezogelin Oflazoglu, Ph.D., Carol Morris-Tilden, B.S., Ivan Stone, B.S., Renee McCormick, B.S., Paul Carter, Ph.D., Hanspeter Gerber, Ph.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2492.
https://doi.org/10.1182/blood.V108.11.2492.2492
Published: 2006
Journal Articles

The Humanized Anti-CD40 Antibody, SGN-40, Promotes Apoptosis Signaling and Is Effective in Combination with Standard Therapies in Lymphoma Xenograft Models.

Timothy S. Lewis, PhD, May S.K. Sutherland, Ph.D., Mechthild Jonas, Ph.D., Charles G. Cerveny, M.S., Renee McCormick, B.S., Alan F. Wahl, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2499.
https://doi.org/10.1182/blood.V108.11.2499.2499
Published: 2006